Jonathan Wolfe, MD
Procedural Dermatology · Plymouth Meeting, PANPI 1235142084
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $211,491 of the $252,206 with a category attached, or 83.9%. 29 manufacturers reported payments, led by AbbVie at 55.7% of the total. Reporting peaked in 2019 at $104,925 and has fallen 98.8% since, to $1,222 in 2025. Among procedural dermatology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 541 payments — averaging $466.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$141K
- Regeneron Healthcare Solutions, Inc.$55K
- Sanofi$49K
- Novartis$3K
- Johnson & Johnson$1K
- Sun Pharmaceutical Industries Inc.$322
- plus $2K from 23 others
Across 481 payments — averaging $5218.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sun Pharmaceutical Industries Inc.$798K
- Incyte Corporation$715K
- Sanofi US Services Inc.$499K
- Eli Lilly$197K
- Pfizer$162K
- AbbVie$80K
- plus $59K from 4 others
What the payments were for
- Consulting fees$2,8501%
- Speaking & faculty fees$211,49184%
- Travel & lodging$25,78010%
- Food & beverage$11,9365%
- Education$1490%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 227 | $140,575 |
| Regeneron Healthcare Solutions, Inc. | 71 | $55,440 |
| Sanofi | 47 | $49,404 |
| Novartis | 16 | $3,193 |
| Johnson & Johnson(2 entities) | 55 | $1,084 |
| Sun Pharmaceutical Industries Inc. | 16 | $322 |
| Lilly USA, LLC | 16 | $304 |
| UCB, Inc. | 13 | $254 |
| Incyte Corporation | 8 | $199 |
| Pfizer | 9 | $179 |
| LEO Pharma Inc. | 8 | $177 |
| Dermavant Sciences, Inc. | 8 | $175 |
| E.r. Squibb & Sons, L.L.C. | 7 | $140 |
| Amgen | 5 | $127 |
| Galderma Laboratories, L.p. | 7 | $123 |
| Genentech USA, Inc. | 6 | $93 |
| Arcutis Biotherapeutics, Inc. | 4 | $75 |
| Helsinn Therapeutics (U.S.), Inc. | 5 | $73 |
| Boehringer Ingelheim | 2 | $67 |
| Organon | 2 | $29 |
| Botanix SB Inc | 1 | $28 |
| Abbott | 1 | $24 |
| Journey Medical Corporation | 1 | $21 |
| Dermira, Inc. | 1 | $21 |
| Promius Pharma LLC | 1 | $20 |
| Almirall LLC | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Verrica Pharmaceuticals Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$252,206 in reported general payments places this provider in the 95th percentile of 26 procedural dermatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 14 | $51,252 |
| Betamethasone Valerate | 14 | $2,072 |
| Ketoconazole | 72 | $1,501 |
| Clobetasol Propionate | 25 | $1,292 |
| Metronidazole | 19 | $1,055 |
| Triamcinolone Acetonide | 68 | $767 |
| Fluorouracil | 12 | $759 |
| Mometasone Furoate | 38 | $557 |
| Betamethasone Dipropionate | 13 | $381 |
| Cephalexin | 11 | $243 |
| Hydrocortisone | 26 | $220 |
| Prednisone | 19 | $49 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Plymouth Meeting
- Stuart GlasserGreensburg$13K
- Danielle DehoratiusBryn Mawr$12K
- Anthony SantoroDoylestown$8K
- Barbara MathesPhiladelphia$7K
- Vincent HerbstWilliamsport$4K
- Elizabeth AndersonCamp Hill$3K
- John BartonEnola$2K
- Anne AngelesPhiladelphia$2K
- Louis BrownPhiladelphia$1K
- Carol NeishPittsburgh$518
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.